+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sepsis Diagnostic Market by Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sepsis Diagnostic Market by Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Sepsis Diagnostic Market by Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311190
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sepsis Diagnostic Market grew from USD 611.80 million in 2024 to USD 674.24 million in 2025. It is expected to continue growing at a CAGR of 10.02%, reaching USD 1.08 billion by 2030.

Sepsis Diagnostics Redefined by Rising Clinical Demands

Sepsis remains one of the foremost challenges confronting modern healthcare, claiming hundreds of thousands of lives annually and driving intensive resource utilization across institutions. Advances in early detection have demonstrated the potential to drastically reduce mortality rates, shifting the focus toward diagnostic platforms that deliver greater speed, precision, and actionable data. As the global burden of sepsis escalates, clinicians and policymakers alike demand solutions that transcend traditional paradigms of blood culture and manual assays.

Innovation in sepsis diagnostics is no longer optional; it is essential. Emerging needs for rapid, point‐of‐care testing, real‐time data integration, and nuanced biomarker profiling have converged to reshape investment priorities and stimulate cross‐disciplinary collaboration. From molecular biologists developing next‐generation sequencing panels to software engineers designing predictive analytics dashboards, the imperative is clear: harness transformative technologies to enable earlier intervention and optimize patient outcomes.

Converging Technologies and Shifting Regulations Transform Diagnostics

The landscape of sepsis diagnostics is undergoing profound transformation as convergent technologies erode longstanding barriers to rapid detection. Artificial intelligence algorithms now mine complex patterns in high‐dimensional data, augmenting the interpretive power of molecular platforms. The integration of digital microscopy and imaging flow cytometry is accelerating pathogen identification while minimizing manual oversight. Simultaneously, advances in multiplex PCR and targeted sequencing have expanded biomarker panels beyond conventional inflammatory markers, offering clinicians a granular view of host response and microbial landscape.

Regulatory milestones have further catalyzed these shifts. Recent clearances for innovative point-of-care analyzers under emergency authorizations have paved the way for permanent approvals, setting new benchmarks for time-to-result. On the policy front, incentivizing domestic manufacturing has spurred investments in localized reagent production and analyzer assembly. This convergence of scientific breakthroughs and supportive regulatory frameworks is forging a new era in sepsis management, one defined by integrated platforms, data interoperability, and precision-guided decision support.

Navigating New Tariff Realities in US Diagnostic Supplies

The introduction of higher tariffs on imported diagnostic instruments and reagents has introduced fresh complexities to supply chain management and pricing strategies. Manufacturers reliant on component imports are recalibrating sourcing models, either by relocating production lines or by renegotiating agreements with overseas suppliers. This realignment has translated into incremental cost pressures for reagents such as biomarker kits and culture media, as well as for analyzers procured from international equipment vendors.

Hospitals and diagnostic laboratories, grappling with constrained budgets, are increasingly evaluating the total cost of ownership rather than unit price alone. Extended service agreements and bundled software licenses have emerged as strategic levers to offset upfront tariffs, while a growing emphasis on local reagent manufacture is fostering collaboration between global players and regional contract manufacturers. At the same time, currency fluctuations amplify these headwinds, driving procurement teams to adopt flexible procurement contracts and hedging mechanisms. The net effect is a more resilient but cost‐sensitive market, where agility in supply chain execution and pricing innovation dictate competitive positioning.

Unveiling the Intricacies of Market Segmentation

The market’s complexity unfolds vividly through its layered segmentation. In terms of instruments, centralized analyzers compete with rapid point-of-care devices to deliver actionable results; whereas reagents and kits extend from foundational culture media to high‐sensitivity biomarker assays; and software and services bridge consultancy support with advanced data management architectures. Meanwhile, diagnostic workflows leverage an array of technologies, from traditional ELISA methods-distinguishing competitive assay formats from sandwich configurations-to the intricate channels of flow cytometry, where conventional cytometers coexist alongside imaging platforms. Meanwhile, sequencing strategies balance the depth of whole genome approaches against the focused precision of targeted panels, even as multiplex PCR assays deliver rapid, simultaneous detection of key pathogens.

End users span high-throughput diagnostic laboratories and sprawling hospital networks alongside clinics and outpatient centers striving to expand access. Each setting imposes unique demands: reference laboratories capitalize on volume and advanced instrumentation, tertiary care hospitals integrate data from multiple modalities, and ambulatory care centers prioritize minimal footprint and ease of use. Distribution pathways further diversify market entry, as manufacturers weigh the direct relationship benefits of in-house sales teams against the scalability and reach afforded by distributors and e-commerce partners. This mosaic of product, technology, user environment, and channel underscores the need for holistic strategies that align portfolio innovation with evolving customer requirements.

Regional Dynamics Shaping Sepsis Diagnostic Progress

Across the Americas, established reimbursement frameworks and consolidated healthcare clusters have accelerated adoption of next-generation sepsis diagnostics. The United States leads in institutional procurements of high-throughput analyzers and integrated software suites, while Latin American markets are witnessing gradual uptake spurred by regional partnerships and government‐led diagnostic initiatives. Clinical laboratories in major urban centers continue to expand their molecular testing capabilities, buoyed by favorable payer coverage and robust research collaborations.

In Europe, Middle East, and Africa, regulatory harmonization under the In Vitro Diagnostic Regulation has elevated quality benchmarks, albeit introducing transitional timelines that extend product launch schedules. Mature Western European markets demand fully validated platforms with seamless hospital information system integration, whereas emerging Gulf Cooperation Council nations exhibit strong appetite for rapid point-of-care solutions in light of limited diagnostic infrastructure. Sub-Saharan Africa presents pockets of need where decentralized testing models and mobile diagnostic units are gaining traction to address resource constraints.

Asia-Pacific stands out for its dynamic growth trajectory. China’s domestic manufacturers are scaling next-generation sequencing and multiplex PCR platforms to satisfy internal demand, while Southeast Asian governments are investing in nationwide sepsis surveillance and point-of-care deployment. Japan and Australia continue to refine national test reimbursement policies, promoting adoption of cutting-edge biomarker assays in tertiary hospitals. This regional tapestry of regulatory diversity, investment incentives, and local innovation pathways underscores the critical importance of tailored market entry approaches.

Strategic Moves of Leading Diagnostic Innovators

Leading diagnostic innovators are forging differentiated paths to capture share in the evolving sepsis space. Company A has embarked on strategic acquisitions to bolster its molecular testing portfolio, integrating targeted sequencing capabilities with AI-driven analytics to support predictive modeling. Company B has invested heavily in modular point-of-care platforms that pair multiplex PCR cartridges with cloud-based result reporting, enabling rapid deployment in emergency and intensive care units. Company C’s emphasis on reagent reagent optimization and streamlined culture media formulations has yielded cost efficiencies that underpin competitive reagent pricing in price-sensitive markets.

Meanwhile, Company D has prioritized software and service frameworks, establishing global consulting practices that guide hospitals through the implementation of electronic decision support systems. Partnerships between established instrument vendors and specialized biotech firms are creating bundled offerings that combine hardware reliability with proprietary biomarker assays. Across the board, these players are channeling resources into localized manufacturing collaborations, regulatory dossier preparation, and post-market surveillance mechanisms, ensuring that product rollouts align with regional nuances and quality standards.

Driving Growth Through Targeted Strategic Actions

Industry leaders should prioritize the acceleration of point-of-care platform deployments in high-acuity settings, ensuring that frontline clinicians have immediate access to actionable data. Investing in integrated software ecosystems that harmonize electronic health records with diagnostic outputs will unlock greater clinical value and bolster differentiation in competitive procurements. Strengthening relationships with regional contract manufacturers can mitigate tariff exposures while enhancing supply chain resilience and responsiveness.

Further, forging strategic alliances with academic and clinical research centers will amplify validation efforts and expedite regulatory approvals for novel biomarker assays. Diversifying distribution networks by blending direct sales teams in core markets with distributor and e-commerce channels in emerging territories can optimize market penetration. Committing to post-market surveillance and continuous performance monitoring will not only safeguard patient safety but also generate real-world evidence to support reimbursement negotiations. By adopting a holistic, value-based proposition, industry leaders can navigate evolving cost pressures and regulatory frameworks while sustaining growth.

A Rigorous Framework Underpinning Our Analysis

This report draws upon a robust research framework that combines in-depth primary interviews with industry executives, laboratory directors, and key opinion leaders alongside comprehensive secondary research from peer‐reviewed journals, regulatory databases, and patent filings. Quantitative data were validated through vendor briefings and an extensive review of clinical trial registries. Market segmentation definitions were informed by real-world practice patterns and cross‐referenced against international regulatory classifications.

Our methodological rigor extends to triangulation of multiple data sources, ensuring that findings reflect both macroeconomic trends and nuanced operational insights. Qualitative perspectives were captured through clinician surveys and focus group discussions, providing context for adoption drivers and pain points. All data inputs underwent a structured validation process, including consistency checks, outlier analysis, and iterative feedback loops with subject matter experts. This multi-layered approach guarantees a high degree of analytical accuracy and actionable relevance for stakeholders navigating the sepsis diagnostics landscape.

Bringing It All Together for Strategic Clarity

Sepsis diagnostics stand at the nexus of technological innovation, regulatory evolution, and shifting economic forces. The confluence of automated analyzers, advanced molecular assays, and intelligent data platforms is redefining the speed and accuracy of pathogen detection. At the same time, tariff adjustments and supply chain realignments underscore the imperative for flexible manufacturing and strategic pricing models.

By dissecting market segmentation across products, technologies, end users, and distribution channels, we uncover critical inflection points where targeted investments yield disproportionate returns. Regional nuances further illustrate the varying demands and growth vectors across the Americas, EMEA, and Asia-Pacific, while competitive analyses spotlight the strategic imperatives guiding leading players. Taken together, these insights form a cohesive blueprint for decision makers tasked with navigating the complexities of sepsis diagnostics and ensuring that patients receive timely, data-driven care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Instruments
      • Analyzers
      • Point-Of-Care Devices
    • Reagents & Kits
      • Biomarker Kits
      • Culture Media
    • Software & Services
      • Consulting Services
      • Data Management Software
  • Technology
    • ELISA
      • Competitive ELISA
      • Sandwich ELISA
    • Flow Cytometry
      • Conventional Flow Cytometry
      • Imaging Flow Cytometry
    • NGS
      • Targeted Sequencing
      • Whole Genome Sequencing
    • PCR
      • Multiplex PCR
      • Real-Time PCR
  • End User
    • Ambulatory Care Centers
      • Clinics
      • Outpatient Centers
    • Diagnostic Laboratories
      • Clinical Laboratories
      • Reference Laboratories
    • Hospitals
      • General Hospitals
      • Tertiary Care Hospitals
  • Distribution Channel
    • Direct
    • Indirect
      • Distributors
      • E-Commerce
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Luminex Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sepsis Diagnostic Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Analyzers
8.2.2. Point-Of-Care Devices
8.3. Reagents & Kits
8.3.1. Biomarker Kits
8.3.2. Culture Media
8.4. Software & Services
8.4.1. Consulting Services
8.4.2. Data Management Software
9. Sepsis Diagnostic Market, by Technology
9.1. Introduction
9.2. ELISA
9.2.1. Competitive ELISA
9.2.2. Sandwich ELISA
9.3. Flow Cytometry
9.3.1. Conventional Flow Cytometry
9.3.2. Imaging Flow Cytometry
9.4. NGS
9.4.1. Targeted Sequencing
9.4.2. Whole Genome Sequencing
9.5. PCR
9.5.1. Multiplex PCR
9.5.2. Real-Time PCR
10. Sepsis Diagnostic Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.2.1. Clinics
10.2.2. Outpatient Centers
10.3. Diagnostic Laboratories
10.3.1. Clinical Laboratories
10.3.2. Reference Laboratories
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Tertiary Care Hospitals
11. Sepsis Diagnostic Market, by Distribution Channel
11.1. Introduction
11.2. Direct
11.3. Indirect
11.3.1. Distributors
11.3.2. E-Commerce
12. Americas Sepsis Diagnostic Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sepsis Diagnostic Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sepsis Diagnostic Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. bioMérieux SA
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Abbott Laboratories
15.3.5. Becton, Dickinson and Company
15.3.6. Siemens Healthineers AG
15.3.7. QIAGEN N.V.
15.3.8. DiaSorin S.p.A.
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Luminex Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SEPSIS DIAGNOSTIC MARKET MULTI-CURRENCY
FIGURE 2. SEPSIS DIAGNOSTIC MARKET MULTI-LANGUAGE
FIGURE 3. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BIOMARKER KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 89. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 90. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 91. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 93. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 94. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 95. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 96. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 99. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 182. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 184. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 193. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 195. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 197. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 199. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 202. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 223. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 225. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 226. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 227. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 229. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 230. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 231. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 232. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 234. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 238. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 241. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 244. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 247. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 250. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 298. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 302. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 304. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 307. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 310. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 328. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 330. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 331. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 332. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 334. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 335. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2018-2030 (USD MILLION)
TABLE 336. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 337. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 339. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 340. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 342. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2018-2030 (USD MILLION)
TABLE 343. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 344. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 345. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 346. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 347. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 348. FINLAND SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
T

Companies Mentioned

The companies profiled in this Sepsis Diagnostic market report include:
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN N.V.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Luminex Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 674.24 Million
Forecasted Market Value ( USD ) by 2030 $ 1080 Million
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Sepsis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sepsis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Sepsis Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Sepsis Diagnostics Market: Analysis By Technology, Product, Method, Pathogen Type, Test Type, End-User, Region Size, Trends and Forecast up to 2029 - Product Image

Sepsis Diagnostics Market: Analysis By Technology, Product, Method, Pathogen Type, Test Type, End-User, Region Size, Trends and Forecast up to 2029

  • Report
  • 205 Pages
  • Global
From
Sepsis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Sepsis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Sepsis Test Market

The Sepsis Test market is a subset of the Diagnostics industry, focused on the detection and diagnosis of sepsis. Sepsis is a life-threatening condition caused by the body's response to an infection, and early diagnosis is critical for successful treatment. Sepsis tests are used to detect the presence of sepsis-causing bacteria in the blood, and to identify the type of bacteria present. Tests may also be used to monitor the progress of treatment. Sepsis tests are typically performed in a laboratory setting, and may include blood cultures, urine cultures, and other tests. Tests may also be performed using point-of-care devices, which allow for rapid diagnosis in the clinical setting. Companies in the Sepsis Test market include Abbott, Becton Dickinson, bioMérieux, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.